Financials

  • Market Capitalization 641.19 M
  • Employee 146
  • Founded 2019
  • CEO N/A
  • Website www.primemedicine.com
  • Headquarter Delaware, United States
  • FIGI BBG011RT3R55
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.57
市销率
111.44

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

新闻